Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'.
Giuseppe Alvise RamirezEmanuel Della-TorreLuca MoroniMona-Rita YacoubLorenzo Dagnanull nullPublished in: Annals of the rheumatic diseases (2021)